Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 Protalix BiotherapeuticsScancellMedicenna TherapeuticsGalena BiopharmaAltimmune
SymbolNYSEAMERICAN:PLXLON:SCLPTSE:MDNANYSE:SLSNYSE:ALT
Price Information
Current Price$0.21GBX 7.25C$1.41$0.13$2.10
52 Week RangeBuyN/AN/AN/ABuy
Analyst Ratings
Consensus RecommendationBuyN/AN/AN/ABuy
Consensus Price Target$3.00N/AN/AN/AN/A
% Upside from Price Target1,328.57% upsideN/AN/AN/AN/A
Trade Information
Market Cap$33.76 million£33.74 millionC$37.16 million$30.70 million$33.99 million
BetaN/AN/AN/AN/AN/A
Average Volume414,818536,96634,23611,192,075762,773
Sales & Book Value
Annual RevenueN/AN/AN/AN/AN/A
Price / SalesN/AN/AN/AN/AN/A
CashflowN/AGBX 0.99 per shareC$0.05 per shareN/AN/A
Price / CashN/A7.3525.95N/AN/A
Book ValueN/AGBX 2.40 per shareC$0.06 per shareN/AN/A
Price / BookN/AN/AN/AN/AN/A
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSN/AGBX (1.50)C($0.19)N/AN/A
Trailing P/E Ratio0.00N/AN/A0.000.00
Forward P/E Ratio
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/AN/AN/A
Current RatioN/A5.86%2.08%N/AN/A
Quick RatioN/A5.46%2.03%N/AN/A
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
Employees18419N/AN/AN/A
Shares Outstanding148.38 million465.36 million28.80 million225.99 million13.45 million
Next Earnings Date11/6/2019 (Estimated)9/23/2019 (Estimated)11/11/2019 (Estimated)11/21/2019 (Estimated)11/12/2019 (Estimated)
OptionableOptionableNot OptionableNot OptionableNot OptionableOptionable
 Protalix BiotherapeuticsScancellMedicenna TherapeuticsGalena BiopharmaAltimmune

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel